224 related articles for article (PubMed ID: 36413004)
1. [Irreversible electroporation: present and future in the treatment of hepatocellular carcinoma].
Cano D; Lasarte JJ; Vivas I
An Sist Sanit Navar; 2022 Nov; 45(3):. PubMed ID: 36413004
[TBL] [Abstract][Full Text] [Related]
2. Irreversible Electroporation For Hepatocellular Carcinoma: Longer-Term Outcomes At A Single Centre.
Freeman E; Cheung W; Kavnoudias H; Majeed A; Kemp W; Roberts SK
Cardiovasc Intervent Radiol; 2021 Feb; 44(2):247-253. PubMed ID: 33051707
[TBL] [Abstract][Full Text] [Related]
3. Single-center nonrandomized clinical trial to assess the safety and efficacy of irreversible electroporation (IRE) ablation of liver tumors in humans: Short to mid-term results.
Frühling P; Nilsson A; Duraj F; Haglund U; Norén A
Eur J Surg Oncol; 2017 Apr; 43(4):751-757. PubMed ID: 28109674
[TBL] [Abstract][Full Text] [Related]
4. The Safety and Efficacy of Irreversible Electroporation for Large Hepatocellular Carcinoma.
Zeng J; Liu G; Li ZH; Yang Y; Fang G; Li RR; Xu KC; Niu L
Technol Cancer Res Treat; 2017 Feb; 16(1):120-124. PubMed ID: 27837054
[TBL] [Abstract][Full Text] [Related]
5. Irreversible Electroporation in the Treatment of Hepatocellular Carcinoma.
Lencioni R; Crocetti L; Narayanan G
Tech Vasc Interv Radiol; 2015 Sep; 18(3):135-9. PubMed ID: 26365542
[TBL] [Abstract][Full Text] [Related]
6. Irreversible Electroporation Can Effectively Ablate Hepatocellular Carcinoma to Complete Pathologic Necrosis.
Cheng RG; Bhattacharya R; Yeh MM; Padia SA
J Vasc Interv Radiol; 2015 Aug; 26(8):1184-8. PubMed ID: 26119204
[TBL] [Abstract][Full Text] [Related]
7. Irreversible electroporation for unresectable hepatocellular carcinoma: initial experience and review of safety and outcomes.
Cheung W; Kavnoudias H; Roberts S; Szkandera B; Kemp W; Thomson KR
Technol Cancer Res Treat; 2013 Jun; 12(3):233-41. PubMed ID: 23369152
[TBL] [Abstract][Full Text] [Related]
8. Irreversible electroporation versus radiofrequency ablation for hepatocellular carcinoma: a single centre propensity-matched comparison.
Freeman E; Cheung W; Ferdousi S; Kavnoudias H; Majeed A; Kemp W; Roberts SK
Scand J Gastroenterol; 2021 Aug; 56(8):942-947. PubMed ID: 34057003
[TBL] [Abstract][Full Text] [Related]
9. Irreversible electroporation: Beyond the limits of tumor ablation.
Alonso-González R; Abadal Villayandre JM; Gálvez Gonzalez E; Álvarez Perez MJ; Méndez Alonso S; de Gregorio Ariza MA
Radiologia (Engl Ed); 2024; 66(1):47-56. PubMed ID: 38365354
[TBL] [Abstract][Full Text] [Related]
10. Irreversible Electroporation of Recurrent Hepatocellular Carcinoma After Liver Transplantation: Report of Two Cases.
Akhan O; Sarıkaya Y; Köksal A; Ünal E; Çiftçi T; Akıncı D
Cardiovasc Intervent Radiol; 2021 May; 44(5):807-811. PubMed ID: 33655357
[TBL] [Abstract][Full Text] [Related]
11. Irreversible electroporation of a hepatocellular carcinoma lesion adjacent to a transjugular intrahepatic portosystemic shunt stent graft.
Niessen C; Jung EM; Wohlgemuth WA; Trabold B; Haimerl M; Schreyer A; Stroszczynski C; Wiggermann P
Korean J Radiol; 2013; 14(5):797-800. PubMed ID: 24043975
[TBL] [Abstract][Full Text] [Related]
12. Ablation of colorectal liver metastases by irreversible electroporation: results of the COLDFIRE-I ablate-and-resect study.
Scheffer HJ; Nielsen K; van Tilborg AA; Vieveen JM; Bouwman RA; Kazemier G; Niessen HW; Meijer S; van Kuijk C; van den Tol MP; Meijerink MR
Eur Radiol; 2014 Oct; 24(10):2467-75. PubMed ID: 24939670
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of tolerability and efficacy of irreversible electroporation (IRE) in treatment of Child-Pugh B (7/8) hepatocellular carcinoma (HCC).
Bhutiani N; Philips P; Scoggins CR; McMasters KM; Potts MH; Martin RC
HPB (Oxford); 2016 Jul; 18(7):593-9. PubMed ID: 27346140
[TBL] [Abstract][Full Text] [Related]
14. Intratumoral STING Agonist Injection Combined with Irreversible Electroporation Delays Tumor Growth in a Model of Hepatocarcinoma.
Lasarte-Cia A; Lozano T; Cano D; Martín-Otal C; Navarro F; Gorraiz M; Casares N; Vivas I; Lasarte JJ
Biomed Res Int; 2021; 2021():8852233. PubMed ID: 33575350
[TBL] [Abstract][Full Text] [Related]
15. Irreversible Electroporation versus Radiofrequency Ablation: Comparison of Systemic Immune Responses in Patients with Hepatocellular Carcinoma.
Sugimoto K; Kakimi K; Takeuchi H; Fujieda N; Saito K; Sato E; Sakamaki K; Moriyasu F; Itoi T
J Vasc Interv Radiol; 2019 Jun; 30(6):845-853.e6. PubMed ID: 31126596
[TBL] [Abstract][Full Text] [Related]
16. Irreversible electroporation for nonthermal tumor ablation in patients with hepatocellular carcinoma: initial clinical experience in Japan.
Sugimoto K; Moriyasu F; Kobayashi Y; Saito K; Takeuchi H; Ogawa S; Ando M; Sano T; Mori T; Furuichi Y; Nakamura I
Jpn J Radiol; 2015 Jul; 33(7):424-32. PubMed ID: 26032929
[TBL] [Abstract][Full Text] [Related]
17. Irreversible Electroporation in Hepatopancreaticobiliary Tumours.
Ruarus AH; Vroomen LGPH; Puijk RS; Scheffer HJ; Zonderhuis BM; Kazemier G; van den Tol MP; Berger FH; Meijerink MR
Can Assoc Radiol J; 2018 Feb; 69(1):38-50. PubMed ID: 29458954
[TBL] [Abstract][Full Text] [Related]
18. Irreversible Electroporation for Unresectable Hepatocellular Carcinoma: Initial Experience.
Kalra N; Gupta P; Gorsi U; Bhujade H; Chaluvashetty SB; Duseja A; Singh V; Dhiman RK; Chawla YK; Khandelwal N
Cardiovasc Intervent Radiol; 2019 Apr; 42(4):584-590. PubMed ID: 30697637
[TBL] [Abstract][Full Text] [Related]
19. Irreversible electroporation in primary and metastatic hepatic malignancies: A review.
Lyu T; Wang X; Su Z; Shangguan J; Sun C; Figini M; Wang J; Yaghmai V; Larson AC; Zhang Z
Medicine (Baltimore); 2017 Apr; 96(17):e6386. PubMed ID: 28445252
[TBL] [Abstract][Full Text] [Related]
20. The latest research progress on minimally invasive treatments for hepatocellular carcinoma.
Zou YW; Ren ZG; Sun Y; Liu ZG; Hu XB; Wang HY; Yu ZJ
Hepatobiliary Pancreat Dis Int; 2023 Feb; 22(1):54-63. PubMed ID: 36041973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]